Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 2, 2010, Pages 198-202

  Kim, Sang Yong ^a   Seok, Jae Yeon ^b   Han, Seok Joo ^c   Koh, Hong ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

aspartate aminotransferase to platelet ratio index; biliary atresia; cirrhosis; liver fibrosis; Metavir classification

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ACCURACY; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BILE DUCT ATRESIA; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER EXAMINATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PORTOENTEROSTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BILIARY ATRESIA; BLOOD PLATELETS; FEMALE; HUMANS; INFANT; LIVER CIRRHOSIS; MALE; REFERENCE VALUES; ROC CURVE;

EID: 77955231355     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181da1d98     Document Type: Article

References (37)

1. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-529
2. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14.
3. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526
4. de Lédinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using Fibroscan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelet ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-450
5. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-481
6. Castera L, Negre I, Samii K, et al. Pain experienced during percutaneous liver biopsy. Hepatology 1999;30:1529-1530
7. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002;36:152-160
8. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495-500.
9. Bonny C, Rayssiguier R, Ughetto S, et al. Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol 2003;27:1021-1025
10. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2006;55:403-408
11. Ohi R, Ibrahim M. Biliary atresia. Semin Pediatr Surg 1992;1:115-124
12. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
13. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-293
14. Ganne-Carrié N, Ziol M, de Lédinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-1517
15. Dickson ER, Murtaugh PA, Wiesner RH, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992;103:1893-1901
16. Roll J, Boyer JL, Barry D, et al. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
17. Saadeh S, Cammel G, Carey WD, et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001;33:196-200.
18. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000;14:543-548
19. Batts KP, Ludwig J. Chronic hepatitis an update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417
20. Bedossa P, Dargére D, Paradis V. Sampling variability of liver biopsy in chronic hepatitis C. Hepatology 2003;38:1449-1457 (Pubitemid 37466971)
21. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618
22. Siddique I, El-Naga HA, Madda JP, et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427-432
23. Toshimichi H, Takashi S, Takuya K, et al. Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. J Pediatr Surg 2000;35:1643-1646
24. Hiroyuki K, Kentaro H, Atsuyuki Y, et al. Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia. J Pediatr Surg 1999;34:1791-1794
25. Toshimichi H, Takuya K, Takashi S, et al. Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia. J Pediatr Surg 2001;36:1609-1612
26. Hiroyuki K, Zhi-Xin L, Atsuyuki Y, et al. Clinical evaluation of serum levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases as predictors of progressive fibrosis in postoperative biliary atresia patients. J Pediatr Surg 2002;37:1030-1033
27. Hiroyuki K, Tsuyoshi T, Atsuyuki Y, et al. Are serum prolyl 4-hydroxylase useful as noninvasive markers of liver fibrosis in patients with biliary atresia? J Pediatr Surg 2005;40:1366-1367
28. Pape L, Olsson K, Petersen C, et al. Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transpl 2009;15:876-882
29. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase- to-platelet ratio index for the prediction of hepatitis C-related fibrosis: systemic review. Hepatology 2007;46:912-921
30. Wilson LE, Torbenson M, Astemborski J, et al. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology 2006;43:788-795
31. Lichtinghagen R, Bahr MJ. Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev Mol Diagn 2004;4:715-726
32. Al-Mohr H, Cooper C, Murphy T, et al. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-confected patients. HIV Med 2005;6:375-378
33. Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42:1373-1381
34. Cales P, de Ledinghen V, Halfon P, et al. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28:1352-1362
35. Ohi R. Biliary atresia. A surgical perspective. Clin Liver Dis 2000;4: 779-804.
36. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 2002;35:1297-1304
37. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr 2004;144:123-125